Looking for product information? Go to the HPRA website
Showing 1 from 1 results
Teva welcomes Medicines for Ireland’s report into Value Added Medicines
‘Value Added Medicines’ could offer a wide range of improvements and benefits for patients, healthcare professionals and the HSE.
Date of preparation: February 2023
Reference: COB-IE-NP-00016 (V7.0)